Hemochromatosis associated with endothelial dysfunction: Evidence for the role of iron stores in early atherogenesis

Vascular Medicine

Volumn 4, Issue 3, 1999, Pages 147-148

  Lekakis, John ^a,b   Papamichael, Christos ^a   Stamatelopoulos, Kimon ^a   Cimponeriu, Adriana ^a   Voutsas, Anastasios ^a   Vemmos, Konstantinos ^a   Mavrikakis, Myron ^a   Stamatelopoulos, Stamatios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Endothelial function; Hemochromatosis; Iron stores

Indexed keywords

IRON;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BRACHIAL ARTERY; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HEMOCHROMATOSIS; HUMAN; IRON STORAGE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0032883363     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358836x9900400305     Document Type: Article

References (6)

1. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F, for the Bruneck Study Group. Body iron stores and the risk of carotid atherosclerosis. Prospective results from the Bruneck Study. Circulation 1997; 96: 3300-307.
2. Salonen JT, Korpela H, Nyyssonen K et al. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med 1995; 237: 161-68.
3. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997; 30: 325-33.
4. Celermajer DS, Sorensen KE. Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-15.
5. Anderson TJ. Meredith IT. Charbonneau F et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 1996; 93: 1647-50.
6. Porreca E, Ucchino S, Di Febbo C et al. Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb 1994; 14: 299-304.